Gilead Sciences
$65.42
24H
Market Cap
Volume
Supply
Price Chart
About Gilead Sciences - GILD
Gilead Sciences, Inc. is a biopharmaceutical company known primarily for its antiviral drugs used in the treatment of HIV, hepatitis B, hepatitis C, and influenza. They also have a range of therapeutic products and are actively involved in research and development targeting various infectious diseases, inflammatory and respiratory conditions, and oncological disorders.
What are Gilead Sciences's core values and mission statement?
Gilead Sciences, Inc.'s core values include integrity, inclusion, teamwork, accountability, and excellence. Their mission is to discover, develop, and commercialize innovative therapeutics in areas of unmet medical need to improve patient care.
Who founded Gilead Sciences and when?
Gilead Sciences, Inc. was founded by Michael L. Riordan in 1987.
Who leads Gilead Sciences?
As of the time of your query, Daniel O'Day serves as the Chairman and Chief Executive Officer of Gilead Sciences, Inc.
Where is Gilead Sciences located, and what is its base country?
Gilead Sciences, Inc. is headquartered in Foster City, California, United States. Its base country is the United States.
On which exchanges is Gilead Sciences traded?
Gilead Sciences, Inc. is primarily traded on the NASDAQ stock exchange under the ticker symbol GILD.
Historical data
Gilead Sciences (GILD) Price Live Data
The live price of Gilead Sciences (GILD) is $65.42, with a trading volume of 12,109,456 in the last 24 hours. Wrapstocks updates the GILD price in real-time. Gilead Sciences is up 0.23% in the last 24 hours. The company has a live market cap of $81,576,771,584.00 and a supply of 1,246,969,911 GILD stocks.
Gilead Sciences (GILD) is traded on NASDAQ Stock Exchange, and currently, the market is closed; trading will be resumed in 16 hours and 2 minutes.
